Endpoints News 4 févr. 2026 Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio
Endpoints News 4 févr. 2026 UK’s health department expected to spend £1B in pharma trade deal with US
Endpoints News 3 févr. 2026 'Turning around the Titanic': How the incoming PBM reforms will transform CMS
Endpoints News 3 févr. 2026 Ultragenyx unwraps data that may be central to its gene therapy resubmission
Endpoints News 3 févr. 2026 Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Endpoints News 3 févr. 2026 Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
Endpoints News 2 févr. 2026 First 10 Medicare-negotiated drug prices have taken effect: Are seniors really saving money?